Egalet Corp. Company Profile (NASDAQ:EGLT)

About Egalet Corp.

Egalet Corp. logoEgalet Corporation is a specialty pharmaceutical company. The Company is engaged in developing, manufacturing and commercializing treatments for pain and other conditions. The Company's products include OXAYDO and SPRIX Nasal Spray. The Company is developing two late-stage product candidates, ARYMO ER and Egalet-002 using Guardian Technology. The Company's product SPRIX Nasal Spray, which contains ketorolac tromethamine is a non-steroidal anti-inflammatory drug (NSAID) indicated in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level. The Company's product OXAYDO is an approved immediate-release (IR) oxycodone product formulated to deter abuse through snorting. The Company's product candidate, ARYMO ER is an abuse-deterrent (AD), extended-release (ER), oral morphine formulation. The Company's product candidate, Egalet-002, is an abuse-deterrent, extended-release, oral oxycodone formulation.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: EGLT
  • CUSIP:
Key Metrics:
  • Previous Close: $8.34
  • 50 Day Moving Average: $7.07
  • 200 Day Moving Average: $6.55
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.40
  • P/E Growth: 0.00
  • Market Cap: $219.41M
  • Outstanding Shares: 24,543,000
  • Beta: 0.24
Additional Links:
Companies Related to Egalet Corp.:

Analyst Ratings

Consensus Ratings for Egalet Corp. (NASDAQ:EGLT) (?)
Ratings Breakdown: 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $17.67 (97.61% upside)

Analysts' Ratings History for Egalet Corp. (NASDAQ:EGLT)
DateFirmActionRatingPrice TargetDetails
8/6/2016Cantor FitzgeraldSet Price TargetBuy$21.00View Rating Details
3/14/2016Janney Montgomery ScottInitiated CoverageNeutral$8.00View Rating Details
9/30/2015GuggenheimReiterated RatingBuy$24.00View Rating Details
8/7/2015Canaccord GenuityReiterated RatingBuyView Rating Details
3/26/2015JMP SecuritiesBoost Price TargetOutperform$18.00 -> $24.00View Rating Details
9/24/2014Stifel NicolausLower Price TargetBuy$20.00 -> $18.00View Rating Details
(Data available from 8/24/2014 forward)


Earnings History for Egalet Corp. (NASDAQ:EGLT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2016Q216($0.82)($0.97)$3.83 million$3.45 millionViewN/AView Earnings Details
5/10/2016Q116($0.87)($0.76)$3.50 million$2.70 millionViewListenView Earnings Details
3/8/2016Q415($0.91)($0.28)$2.80 million$2.10 millionViewN/AView Earnings Details
11/4/2015Q315($0.90)($0.81)$1.62 million$1.30 millionViewN/AView Earnings Details
8/6/2015Q215($1.02)($0.98)$1.47 millionViewN/AView Earnings Details
5/7/2015($0.98)($1.02)ViewN/AView Earnings Details
3/25/2015Q414($0.69)($0.48)$5.64 millionViewN/AView Earnings Details
11/12/2014Q314($0.77)($0.63)ViewN/AView Earnings Details
8/12/2014Q214($0.42)($0.73)ViewN/AView Earnings Details
5/13/2014Q114($0.16)($1.39)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Egalet Corp. (NASDAQ:EGLT)
Current Year EPS Consensus Estimate: $-3.32 EPS
Next Year EPS Consensus Estimate: $-2.03 EPS


Dividend History for Egalet Corp. (NASDAQ:EGLT)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Egalet Corp. (NASDAQ:EGLT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/6/2016Robert S RadieCEOSell15,000$5.01$75,150.00View SEC Filing  
7/5/2016Robert S RadieCEOSell5,000$4.94$24,700.00View SEC Filing  
7/5/2016Stan MusialCFOSell13,480$5.06$68,208.80View SEC Filing  
7/1/2016Robert S RadieCEOSell5,000$5.07$25,350.00View SEC Filing  
7/1/2016Stan MusialCFOSell10,000$5.06$50,600.00View SEC Filing  
6/30/2016Jeffrey M DaynoInsiderSell536$4.65$2,492.40View SEC Filing  
4/5/2016Deanne F MelloyInsiderSell860$6.96$5,985.60View SEC Filing  
4/5/2016Robert S RadieCEOSell5,000$6.99$34,950.00View SEC Filing  
4/4/2016Robert S RadieCEOSell10,000$6.97$69,700.00View SEC Filing  
1/11/2016Robert S. RadieCEOSell10,000$9.65$96,500.00View SEC Filing  
1/6/2016Robert S. RadieCEOSell5,000$10.52$52,600.00View SEC Filing  
10/6/2015Deanne F MelloyInsiderSell860$11.42$9,821.20View SEC Filing  
10/1/2015Robert S RadieCEOSell15,000$12.27$184,050.00View SEC Filing  
10/1/2015Stan MusialCFOSell8,480$12.32$104,473.60View SEC Filing  
9/30/2015Mark StrobeckInsiderSell5,220$12.56$65,563.20View SEC Filing  
7/8/2015Robert S RadieCEOSell6,000$11.97$71,820.00View SEC Filing  
7/6/2015Robert S RadieCEOSell9,000$12.53$112,770.00View SEC Filing  
7/1/2015Mark StrobeckInsiderSell10,440$12.98$135,511.20View SEC Filing  
7/1/2015Stan MusialCFOSell8,480$13.20$111,936.00View SEC Filing  
4/1/2015Robert S RadieCEOSell11,130$11.25$125,212.50View SEC Filing  
2/3/2015Jeffrey M DaynoInsiderSell2,500$8.87$22,175.00View SEC Filing  
1/2/2015Mark StrobeckInsiderSell3,480$5.09$17,713.20View SEC Filing  
1/2/2015Robert S RadieCEOSell11,130$5.11$56,874.30View SEC Filing  
9/10/2014Robert S RadieCEOSell40,040$9.61$384,784.40View SEC Filing  
9/8/2014Robert S RadieCEOSell49,000$9.74$477,260.00View SEC Filing  
8/13/2014Mark StrobeckInsiderSell5,135$9.20$47,242.00View SEC Filing  
8/11/2014Mark StrobeckInsiderSell5,700$10.28$58,596.00View SEC Filing  
8/7/2014Mark StrobeckInsiderSell3,085$11.50$35,477.50View SEC Filing  
8/7/2014Stan MusialCFOSell13,920$11.05$153,816.00View SEC Filing  
2/11/2014Jean Francois FormelaDirectorBuy41,667$12.00$500,004.00View SEC Filing  
2/11/2014Life Science Ventures SunstoneMajor ShareholderBuy133,333$12.00$1,599,996.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Egalet Corp. (NASDAQ:EGLT)
DateHeadline logoETF’s with exposure to Egalet Corp. : August 17, 2016 (NASDAQ:EGLT) - August 17 at 4:58 PM logoEGALET CORP Financials (NASDAQ:EGLT) - August 16 at 4:53 PM logoAbuse-Deterrent Drugs: A Growing Field (NASDAQ:EGLT) - August 16 at 8:01 AM logoEgalet Corporation Scores Huge Vote Of Support From FDA Advisory Panel For Its ARYMO Compound (NASDAQ:EGLT) - August 12 at 4:48 PM logoEgalet Corp. :EGLT-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:EGLT) - August 12 at 4:48 PM logoValuable Analysts Trends to Observe: Egalet Corporation (NASDAQ:EGLT) , BioDelivery Sciences International, Inc ... - Street Updates (NASDAQ:EGLT) - August 9 at 3:27 PM
News IconNotable Traders Recap: Fairchild Semiconductor Intl Inc (NASDAQ:FCS), Egalet Corp (NASDAQ:EGLT) - NYSE Journal (press release) (NASDAQ:EGLT) - August 8 at 10:07 PM logoFriday Market Review – Stock Gaps Up (NASDAQ:EGLT) - August 8 at 9:36 AM logoEgalet Corporation (EGLT) Jumps 6.82% on August 05 - (NASDAQ:EGLT) - August 6 at 7:58 AM logoFDA committees recommend approval of Eaglet's abuse-deterrent pain medicine (NASDAQ:EGLT) - August 5 at 10:01 PM logoEgalet (EGLT) Receives FDA Panel Recommendation for ARYMO ER for Pain Management (NASDAQ:EGLT) - August 5 at 10:01 PM
News IconFDA Advisory Panels Back Egalet’s (EGLT) Drug; Rackspace Hosting (RAX) Gets Bullish On Possible Takeover Deal (NASDAQ:EGLT) - August 5 at 10:01 PM
News IconEgalet Corp. announces quarterly earnings (EGLT) - BNB Daily (blog) (NASDAQ:EGLT) - August 5 at 4:49 PM logoEGALET CORP Files SEC form 10-Q, Quarterly Report (NASDAQ:EGLT) - August 5 at 4:49 PM logoEgalet reports 2Q loss (NASDAQ:EGLT) - August 5 at 8:16 AM logoEgalet Corporation (EGLT) Jumps 8.09% on August 03 - (NASDAQ:EGLT) - August 4 at 10:30 PM logoEGALET CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial St (NASDAQ:EGLT) - August 4 at 10:30 PM logoU.S. panel backs approval of Egalet's abuse-resistant painkiller (NASDAQ:EGLT) - August 4 at 4:59 PM logoEgalet Announces FDA Advisory Committees Recommend Approval of Abuse-Deterrent ARYMO™ ER (Morphine Sulfate) and Reports Second Quarter 2016 Financial Results (NASDAQ:EGLT) - August 4 at 4:59 PM logoQ2 2016 Egalet Corp Earnings Release - Before Market Open (NASDAQ:EGLT) - August 4 at 7:43 AM logoEgalet Corporation (EGLT) Drops 5.01% on August 01 - (NASDAQ:EGLT) - August 3 at 7:34 AM logoNew Broker Ratings For Egalet Corp (EGLT) - FTSE News (NASDAQ:EGLT) - July 29 at 10:07 PM logoEgalet Corporation (EGLT) Jumps 8.54% on July 27 - (NASDAQ:EGLT) - July 28 at 8:43 AM
News IconIncreased Volatility Noted on Shares of: Egalet Corporation (NASDAQ:EGLT) - Engelwood Daily (NASDAQ:EGLT) - July 23 at 8:53 AM logoEgalet Corporation (EGLT) Jumps 5.47% on July 22 - (NASDAQ:EGLT) - July 23 at 8:53 AM
News IconIncreased Stock Volatility Watch: Egalet Corporation (NASDAQ:EGLT) - Engelwood Daily (NASDAQ:EGLT) - July 22 at 7:58 AM logoEgalet Corporation (EGLT) Jumps 7.59% on July 20 - (NASDAQ:EGLT) - July 21 at 8:17 AM logoEgalet to Host Conference Call and Webcast on August 4, 2016 to Discuss Second Quarter 2016 Financial Results (NASDAQ:EGLT) - July 21 at 6:00 AM logo6:01 am Egalet announces the issuance of two patents by the USPTO for its Guardian Technology (NASDAQ:EGLT) - July 19 at 6:01 AM logoEgalet Announces Issuance of Two New U.S. Patents for Guardian™ Technology (NASDAQ:EGLT) - July 19 at 6:00 AM
News IconEgalet Corporation (NASDAQ:EGLT) Sellers Covered 2.67% of Their Shorts - Consumer Eagle (NASDAQ:EGLT) - July 14 at 4:26 PM logoActive Stocks to Watch: Egalet Corporation (NASDAQ:EGLT), Synchrony Financial (NYSE:SYF), Pfizer Inc. (NYSE:PFE ... - KC Register (NASDAQ:EGLT) - July 13 at 4:59 PM
News IconIncreased Volatility on Shares of: Egalet Corporation (NASDAQ:EGLT) - Engelwood Daily (NASDAQ:EGLT) - July 9 at 8:16 AM logoEgalet Corporation (EGLT) Jumps 5.5% on July 08 - (NASDAQ:EGLT) - July 9 at 8:16 AM
News IconChief Financial Officer of Egalet Corporation (NASDAQ:EGLT), Musial Stan, sells 10,000 shares worth $50,600 (NASDAQ:EGLT) - July 7 at 7:55 AM logoEgalet to Present at Cantor Fitzgerald Healthcare Conference (NASDAQ:EGLT) - July 7 at 6:11 AM logoBroker Outlook For Egalet Corp (EGLT) - Fiscal Standard (NASDAQ:EGLT) - July 6 at 10:37 PM
News IconChief Business Officer of Egalet Corporation (NASDAQ:EGLT), Strobeck Mark, sells 8,700 shares worth $40,716 (NASDAQ:EGLT) - July 6 at 9:31 AM logoETF’s with exposure to Egalet Corp. : July 5, 2016 (NASDAQ:EGLT) - July 5 at 12:52 PM logoBroker Outlook For The Week Ahead Egalet Corp (EGLT) - Fiscal Standard (NASDAQ:EGLT) - July 4 at 4:31 PM
News IconCheck on Share Volatility: Egalet Corporation (NASDAQ:EGLT) - Engelwood Daily (NASDAQ:EGLT) - June 30 at 10:13 PM
News IconEgalet Corporation (NASDAQ:EGLT) Shorted Shares Decreased By 2.67% - Engelwood Daily (NASDAQ:EGLT) - June 30 at 5:01 PM logoEgalet Reveals FDA Advisory Committee Meeting For ARYMO ER Extended-Release Tablets (NASDAQ:EGLT) - June 28 at 1:31 PM logoEgalet Announces FDA Advisory Committee Meeting will Take Place August 4, 2016 for Lead Abuse-Deterrent Candidate ARYMO™ ER (Morphine Sulfate) Extended-Release Tablets (NASDAQ:EGLT) - June 28 at 9:11 AM logoEgalet Corporation (EGLT) is Trading Higher on Unusual Volume for June 23 - (NASDAQ:EGLT) - June 26 at 4:24 PM logoEgalet Corporation (EGLT) Jumps 10.65% on June 23 - (NASDAQ:EGLT) - June 26 at 4:24 PM
News IconShare Volatility Check for: Egalet Corporation (NASDAQ:EGLT) - Press Telegraph (NASDAQ:EGLT) - June 24 at 11:34 AM logoEgalet Corporation (EGLT) Hits New 52-week Low During June 21 Session - (NASDAQ:EGLT) - June 23 at 7:43 AM logoEgalet Corporation (EGLT) Jumps 9.03% on June 22 - (NASDAQ:EGLT) - June 23 at 7:43 AM logoEgalet Corporation (NasdaqGM:EGLT) Stock Momentum Hits EXTREME Weakness - CML News (NASDAQ:EGLT) - June 22 at 4:53 PM


Egalet Corp. (NASDAQ:EGLT) Chart for Wednesday, August, 24, 2016

Last Updated on 8/24/2016 by Staff